J O'Hallahan

Author PubWeight™ 8.55^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease.	Vaccine	2007	1.73
2	Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand.	Vaccine	2007	1.72
3	The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.	Clin Vaccine Immunol	2006	1.31
4	Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials.	Vaccine	2005	1.10
5	Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.	Vaccine	2005	1.01
6	Meningococcal disease epidemiology and control in New Zealand.	N Z Med J	1995	0.84
7	Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants.	Clin Vaccine Immunol	2006	0.81